HRTX
Heron Therapeutics
$0.29
−$0.01 (−4.85%)Oct 29, 2026
Key metrics
The numbers that frame HRTX today
- Market cap
- $55.82M
- Gross margin
- 70.1%
- EV / Sales
- 1.2
- ROIC
- -9.7%
- Div yield
- 0%
- Debt / equity
- 21.5
- 52wk Low
- $0.26
- 52wk High
- $1.58
Growth
Revenue and earnings trend for HRTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about HRTX
Is Heron Therapeutics a good buy?
No. Heron Therapeutics has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Heron Therapeutics is selling at a high price.
What is the market capitalization of HRTX?
Heron Therapeutics's market capitalization is $55.82M.
What is the 52-week high for HRTX stock?
The 52-week high for Heron Therapeutics is $1.58. The current close of $0.29 is 81.3% below that high.
What is the 52-week low for HRTX stock?
The 52-week low for Heron Therapeutics is $0.26. The current close of $0.29 is 12.6% above that low.
Does HRTX stock pay dividends?
Heron Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for HRTX?
Heron Therapeutics's Debt / Equity ratio is 21.48.